期刊文献+

丝裂霉素胸膜腔灌注治疗肺癌恶性胸膜腔积液初报

Primary results of treatment of lung cancer with malignant pleura effusion with mitomycin thoracic cavity perfusion
下载PDF
导出
摘要 目的 观察胸膜腔内灌注丝裂霉素治疗恶性胸膜腔积液的疗效。方法 对15例恶性胸膜腔积液病人采用胸膜腔闭式引流术,1-2d排空胸膜腔积液,后注入100mL生理盐水+20mg丝裂霉素,夹闭引流管4h后开放,间隔1d再同样方法用1次,引流无液体后拔出引流管,4wk后评价疗效。结果 病人呼吸困难明显好转,生活质量明显改善。CR10例,PR3例,NC2例,总有效率86.7%(13/15)。结论 胸膜腔内灌注丝裂霉素能有效控制恶性胸膜腔积液,对晚期肿瘤所致恶性胸水的病人有重要意义。 Objective To observe the efficacy of treating malignant pleural effusion by mitomycin thoracic cavity perfusion. Methods 15 patients with malignant pleural effusion were performed thoracic cavity drainage, evacuation after 1 to 2 days, drainage after 4 hours perfusion with 10ml NS, and 20mg mitomycin. The same procedure was repeated in one day, drainage-tube was removed after no more drainage, and then the efficacy was evaluated after 4 weeks. Results The symptom and quality of life were significantly improved (CR 10 cases, PR 3 cases and NC 2 cases, the efficiency is 87%). Conclusion mitomycin thoracic cavity perfusion could effectively control malignant pleural effusion, and has significance to patients with advanced stage cancer.
作者 王建云
出处 《世界肿瘤杂志》 2005年第3期208-209,共2页 Tumour Journal of the World
关键词 恶性胸膜腔积液 丝裂霉素 治疗 malignant pleural effusion mitomycin therapy
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部